Although HAPC is believed to be related to factors such as hypoxia-inducible factor, erythropoietin (EPO), susceptibility genes (Xu et al., 2015), an imbalance in apoptosis/proliferation, plasma ergothioneine and nitrogen oxide balance, and certain inflammatory factors (Yi et al., 2021)
Following subcutaneous administration in clinical models: Both components demonstrate prolonged absorption with peak plasma concentrations occurring 24-72 hours post-injection GLP3 exhibits approximately 6-day half-life enabling once-weekly dosing Cagrilintide demonstrates 120-165 hour half-life (5-7 days) suitable for weekly administration Lipid conjugation of both peptides enables albumin binding and extended systemic circulation Distribution patterns show systemic exposure with concentration in metabolically active tissues The fatty diacid modifications on both peptides (C20 for GLP3 , eicosanedioic acid for cagrilintide) serve as albumin-binding moieties that dramatically extend plasma residence time compared to native peptides
Prieto Santamara L, del Garca Valle EP, Zanin M et al (2021) Classifying diseases by using biological features to identify potential nosological models
Zimmermann T, Thomas L, Baader-Pagler T, et al
Investig New Drugs 30:12791288 Ozen S, Akyol O, Iraz M, Sogut S, Ozugurlu F, Ozyurt H, Odaci E, Yildirim Z (2004) Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats
Many have as much sugar as a can of soda
